Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Pediatr Res. 2010 Jul;68(1):70–74. doi: 10.1203/PDR.0b013e3181e0cd97

Figure 2.

Figure 2

(A) Respiratory system resistance in cromolyn and imatinib treatment groups compared to air and oxy + vehicle measured by forced oscillometry. □ air + cromolyn; ○ air + vehicle; ◇ oxy+vehicle; ▲oxy+cromolyn; ◆ air + imtinib; ■ oxy+imatinib. Data are means of 6 per group ± SEM. * p < 0.05 v. oxy + vehicle. (B) Respiratory system compliance (B) effects. Data are mean ± SEM. * p < 0.05 v. air + vehicle, **p<.05 v. oxy + vehicle.